维普中文期刊产品整合服务

LncRNA LINC00525 suppresses p21 expression viamRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma

查看全文 作　　者：Panqi [1,2]Fang;Hao [1,3]Chen;Zhifei [1,3]Ma;Chencheng [1,3]Han;Wenda [1,3]Yin;Siwei [1,3]Wang;Hongyu [1,3]Zhu;Wenjia [1]Xia;Jie [1,4,5]Wang;Lin [1]Xu;Tongyan [1,4]Liu;Rong [1,4,5]Yin 高影响力作者 机构地区：[1]Department of Thoracic Surgery,Jiangsu Cancer Hospital,Jiangsu Institute of Cancer Research,the Affiliated Cancer Hospital of Nanjing Medical University,Jiangsu Key Laboratory of Molecular and Translational Cancer Research,Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing,Jiangsu 210009,P.R.China;[2]Department of Pharmacy,Jiangsu Cancer Hospital,Jiangsu Institute of Cancer Research,the Affiliated Cancer Hospital of Nanjing Medical University,Nanjing,Jiangsu 210009,P.R.China;[3]The Fourth Clinical College of Nanjing Medical University,Nanjing,Jiangsu 210009,P.R.China;[4]Department of Scientific Research,Jiangsu Cancer Hospital,Jiangsu Institute of Cancer Research,the Affiliated Cancer Hospital of Nanjing Medical University,Jiangsu Key Laboratory of Molecular and Translational Cancer Research,Nanjing,Jiangsu 210009,P.R.China;[5]Jiangsu Biobank of Clinical Resources,Nanjing,Jiangsu 210009,P.R.China高影响力机构 出　　处：《Cancer Communications》索引2021年第41卷第7期,共19页高影响力期刊 基　　金：National Natural Science Foundation of China,Grant/Award Numbers:81802277,81872378,81802907;China Postdoctoral Science Foundation,Grant/Award Number:2018M642198;Project of Jiangsu Provincial Medical Talent,Grant/Award Number:ZDRCA2016033。 摘　　要：Background:Emerging evidence suggests that long noncoding RNAs(lncRNAs)play crucial roles in various cancers.In the present study,we aim to investigate the function and molecular mechanism of an up-regulated and survivalassociated lncRNA,LINC00525,in lung adenocarcinoma(LUAD).Methods:The expression level of LINC00525 in tissueswas determined by quantitative reverse transcription polymerase chain reaction(RT-qPCR)and in situ hybridization(ISH).The functional role of LINC00525 in LUAD was investigated using gain-and loss-of-function approaches,both in vivo and in vitro.RNA pull-down,RNA immunoprecipitation(RIP),chromatin immunoprecipitation(ChIP),triplex-capture assay,dual-luciferase assay,gene expression microarray,and bioinformatics analysis were used to investigate the potential underlying mechanisms involved.Results:LINC00525 is highly expressed in LUAD cells and tissues.Survival analysis indicated that upregulation of LINC00525 was associated with poor prognosis in patients with LUAD patients.Knockdown of LINC00525 inhibited cell proliferation and cell cycle progression in vitro.In xenograft models,LINC00525 knockdown suppressed tumor growth and tumorigenesis of tumorbearing mice.Mechanistically,LINC00525 epigenetically suppressed p21 transcription by guiding Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit(EZH2)to the p21 promoter through an formation of RNA-DNA triplex with the p21 promoter,leading to increased trimethylation of lysine 27 on histone 3(H3K27me3)of the p21 promoter.In addition,LINC00525 repressed p21 expression post-transcriptionally by enhancing p21mRNA decay.LINC00525 promoted p21mRNAdecay by competitively binding toRNABindingMotif Single Stranded Interacting Protein 2(RBMS2).Conclusion:Our findings demonstrate that LINC00525 promotes the progression of LUAD by reducing the transcription and stability of p21 mRNA in concert with EZH2 and RBMS2,thus suggesting that LINC00525 may be a potential therapeutic target for clinical intervention in LUAD. 关 键 词：lung adenocarcinoma LINC00525 P21 mRNA decay RNA-DNA triplex
相关文献

参考文献(35)

引证文献(3)

耦合文献(1118)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费